CP 55,940

CP 55,940
Legal status
Legal status	CA: Schedule II;
Identifiers
	IUPAC name 2-[(1R,2R,5R)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol;
CAS Number	83002-04-4;
PubChem CID	3086156;
ChemSpider	94668;
UNII	KFY70972J5;
ChEMBL	ChEMBL559612 ;
CompTox Dashboard (EPA)	DTXSID80875516 ;
Chemical and physical data
Formula	C24H40O3
Molar mass	376.581 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O[C@H]1C[C@@H](C2=CC=C(C(C)(C)CCCCCC)C=C2O)[C@H](CCCO)CC1;
	InChI InChI=1S/C24H40O3/c1-4-5-6-7-14-24(2,3)19-11-13-21(23(27)16-19)22-17-20(26)12-10-18(22)9-8-15-25/h11,13,16,18,20,22,25-27H,4-10,12,14-15,17H2,1-3H3/t18-,20-,22-/m1/s1; Key:YNZFFALZMRAPHQ-SYYKKAFVSA-N;

CP 55,940 is a synthetic cannabinoid which mimics the effects of naturally occurring THC (one of the psychoactive compounds found in cannabis). CP 55,940 was created by Pfizer in 1974 but was never marketed. It is currently used as a research tool to study the endocannabinoid system.^[1]

^ Glass M, Dragunow M, Faull RL (March 1997). "Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain". Neuroscience. 77 (2): 299–318. doi:10.1016/s0306-4522(96)00428-9. PMID 9472392. S2CID 40213209.

[1] Glass M, Dragunow M, Faull RL (March 1997). "Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain". Neuroscience. 77 (2): 299–318. doi:10.1016/s0306-4522(96)00428-9. PMID 9472392. S2CID 40213209.

[1]